Share Price and Basic Stock Data
Last Updated: November 8, 2025, 5:57 am
| PEG Ratio | -1.05 |
|---|
Analyst Insight & Comprehensive Analysis
Business Overview and Revenue Trends
BLB Ltd, operating in the Finance & Investments sector, reported a market capitalization of ₹85.0 Cr and a current share price of ₹16.1. The company’s revenue trends have shown significant volatility, with sales recorded at ₹20 Cr in June 2022, peaking at ₹81 Cr in December 2022 before declining to ₹39 Cr in June 2023. A notable recovery occurred in March 2024, with sales surging to ₹205 Cr, followed by a substantial rise to ₹236 Cr in June 2024. However, sales dipped to ₹171 Cr in September 2024 before stabilizing at ₹73 Cr in December 2024. The trailing twelve months (TTM) revenue stood at ₹360 Cr, indicating a fluctuating but upward trend in revenue generation. This inconsistency may reflect changing market conditions or operational challenges faced by the company, which merits further investigation into the underlying factors influencing these variations.
Profitability and Efficiency Metrics
BLB Ltd’s profitability metrics reveal a challenging landscape, with an operating profit margin (OPM) of 26% indicating a strong operational performance relative to many peers in the finance sector. Notably, net profit for the company was ₹7 Cr, yielding a return on equity (ROE) of 3.99% and a return on capital employed (ROCE) of 6.58%. Despite these positives, the company’s interest coverage ratio (ICR) stood at a concerning 0.01x, suggesting potential difficulties in meeting interest obligations, particularly given that borrowings were recorded at ₹0 Cr. The cash conversion cycle (CCC) was reported at 13 days, reflecting efficient working capital management, while the company’s reported earnings per share (EPS) of ₹2.17 in June 2025 indicates a recovering profitability trajectory. However, the inconsistent net profits across quarters, including losses reported in March 2024 and December 2024, highlight ongoing challenges in sustaining profitability.
Balance Sheet Strength and Financial Ratios
BLB Ltd’s balance sheet reveals a robust position with total borrowings recorded at ₹0 Cr and reserves amounting to ₹92 Cr, indicating a lack of debt and a solid equity base. The price-to-book value (P/BV) ratio stood at 0.30x, suggesting that the company is trading at a significant discount compared to its book value, which may attract value investors. However, the company’s total liabilities remained constant at ₹98 Cr for both March 2024 and March 2025, indicating a lack of growth in liabilities despite an increase in equity reserves over the same period. The current ratio maintained at a healthy level suggests adequate liquidity to cover short-term obligations. However, the company’s efficiency metrics show a declining trend in ROCE, which stood at 7% for both FY 2024 and FY 2025, indicating challenges in generating returns on capital employed relative to the equity base.
Shareholding Pattern and Investor Confidence
The shareholding pattern of BLB Ltd reflects a significant shift in investor confidence, with promoter holdings declining from 70.45% in December 2022 to 41.00% by March 2025. Conversely, public shareholding increased from 29.55% to 59.00% over the same period, indicating a growing interest from retail investors. The number of shareholders rose from 8,041 in December 2022 to 13,766 by March 2025, showcasing enhanced retail participation. The foreign institutional investors (FIIs) maintained a minimal stake of 0.11%, suggesting limited confidence from institutional investors in the company’s future prospects. This mixed sentiment among stakeholders highlights the need for management to address concerns regarding profitability and operational stability to regain trust and attract further investment.
Outlook, Risks, and Final Insight
Looking ahead, BLB Ltd faces both opportunities and risks. On the positive side, the recent revenue surge and high operating profit margins position the company favorably within its sector. However, the volatile earnings and declining ROE raise concerns about long-term sustainability. Risks include the potential for further fluctuations in sales, as evidenced by recent quarterly results, and the company’s inability to leverage its balance sheet to drive growth, given its zero borrowing status. The reduction in promoter stake may also signal a lack of confidence from insiders. For the company to enhance its market position, it must focus on stabilizing earnings, improving operational efficiency, and potentially re-engaging with institutional investors. The path forward involves addressing these operational challenges while capitalizing on its strong liquidity position to drive strategic growth initiatives.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors of BLB Ltd
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Modern Shares & Stockbrokers Ltd | 12.6 Cr. | 43.0 | 67.7/36.4 | 50.4 | 44.4 | 0.00 % | 3.32 % | 1.74 % | 10.0 |
| Monarch Networth Capital Ltd | 2,425 Cr. | 305 | 488/280 | 15.7 | 102 | 0.33 % | 33.3 % | 26.2 % | 10.0 |
| Monotype India Ltd | 37.3 Cr. | 0.53 | 2.42/0.46 | 3.62 | 0.02 | 0.00 % | 286 % | % | 1.00 |
| Multipurpose Trading & Agencies Ltd | 4.14 Cr. | 8.36 | 12.6/8.25 | 10.3 | 0.00 % | 3.68 % | 3.38 % | 10.0 | |
| Munoth Financial Services Ltd | 30.3 Cr. | 58.9 | 72.0/47.6 | 20.6 | 0.00 % | 2.41 % | 3.38 % | 10.0 | |
| Industry Average | 6,983.19 Cr | 1,374.58 | 108.16 | 3,835.00 | 0.32% | 21.70% | 14.20% | 7.28 |
Quarterly Result
| Metric | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 20 | 41 | 81 | 77 | 39 | 25 | 44 | 205 | 236 | 171 | 73 | 59 | 56 |
| Expenses | 18 | 38 | 80 | 75 | 36 | 23 | 42 | 208 | 224 | 167 | 80 | 63 | 42 |
| Operating Profit | 2 | 3 | 1 | 2 | 3 | 2 | 2 | -3 | 12 | 4 | -6 | -4 | 15 |
| OPM % | 10% | 7% | 2% | 3% | 9% | 8% | 5% | -1% | 5% | 2% | -8% | -6% | 26% |
| Other Income | -0 | 0 | 0 | 1 | -0 | 0 | 0 | 0 | 0 | 0 | 0 | -0 | 0 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit before tax | 1 | 3 | 1 | 3 | 3 | 2 | 2 | -3 | 12 | 4 | -6 | -4 | 15 |
| Tax % | 21% | 25% | 47% | 16% | 23% | 27% | 26% | -24% | 28% | 17% | -24% | -24% | 23% |
| Net Profit | 1 | 2 | 1 | 2 | 2 | 1 | 1 | -2 | 9 | 3 | -5 | -3 | 11 |
| EPS in Rs | 0.22 | 0.38 | 0.11 | 0.43 | 0.43 | 0.23 | 0.28 | -0.45 | 1.64 | 0.58 | -0.93 | -0.57 | 2.17 |
Last Updated: August 20, 2025, 12:45 pm
Below is a detailed analysis of the quarterly data for BLB Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Sales, as of Jun 2025, the value is 56.00 Cr.. The value appears to be declining and may need further review. It has decreased from 59.00 Cr. (Mar 2025) to 56.00 Cr., marking a decrease of 3.00 Cr..
- For Expenses, as of Jun 2025, the value is 42.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 63.00 Cr. (Mar 2025) to 42.00 Cr., marking a decrease of 21.00 Cr..
- For Operating Profit, as of Jun 2025, the value is 15.00 Cr.. The value appears strong and on an upward trend. It has increased from -4.00 Cr. (Mar 2025) to 15.00 Cr., marking an increase of 19.00 Cr..
- For OPM %, as of Jun 2025, the value is 26.00%. The value appears strong and on an upward trend. It has increased from -6.00% (Mar 2025) to 26.00%, marking an increase of 32.00%.
- For Other Income, as of Jun 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Interest, as of Jun 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Depreciation, as of Jun 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Profit before tax, as of Jun 2025, the value is 15.00 Cr.. The value appears strong and on an upward trend. It has increased from -4.00 Cr. (Mar 2025) to 15.00 Cr., marking an increase of 19.00 Cr..
- For Tax %, as of Jun 2025, the value is 23.00%. The value appears to be increasing, which may not be favorable. It has increased from -24.00% (Mar 2025) to 23.00%, marking an increase of 47.00%.
- For Net Profit, as of Jun 2025, the value is 11.00 Cr.. The value appears strong and on an upward trend. It has increased from -3.00 Cr. (Mar 2025) to 11.00 Cr., marking an increase of 14.00 Cr..
- For EPS in Rs, as of Jun 2025, the value is 2.17. The value appears strong and on an upward trend. It has increased from -0.57 (Mar 2025) to 2.17, marking an increase of 2.74.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: August 22, 2025, 5:30 pm
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 129 | 301 | 62 | 119 | 518 | 194 | 203 | 537 | 355 | 220 | 314 | 539 | 360 |
| Expenses | 132 | 299 | 59 | 117 | 518 | 196 | 200 | 532 | 343 | 211 | 308 | 533 | 351 |
| Operating Profit | -4 | 1 | 3 | 3 | 0 | -2 | 2 | 5 | 13 | 9 | 7 | 7 | 9 |
| OPM % | -3% | 0% | 4% | 2% | 0% | -1% | 1% | 1% | 4% | 4% | 2% | 1% | 2% |
| Other Income | 0 | 0 | -0 | -0 | -0 | 1 | -12 | 0 | 0 | 0 | -2 | 0 | 0 |
| Interest | 0 | 1 | 1 | 1 | 5 | 1 | 2 | 1 | 1 | 1 | 1 | 1 | 1 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit before tax | -4 | 0 | 1 | 1 | -6 | -3 | -12 | 4 | 11 | 8 | 3 | 5 | 8 |
| Tax % | -31% | -168% | -1% | 64% | -8% | 41% | -32% | 72% | 17% | 24% | 26% | 27% | |
| Net Profit | -3 | 1 | 1 | 0 | -5 | -4 | -8 | 1 | 9 | 6 | 3 | 4 | 7 |
| EPS in Rs | -0.57 | 0.14 | 0.14 | 0.06 | -0.98 | -0.77 | -1.52 | 0.21 | 1.78 | 1.14 | 0.49 | 0.73 | 1.25 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 133.33% | 0.00% | -100.00% | 20.00% | -100.00% | 112.50% | 800.00% | -33.33% | -50.00% | 33.33% |
| Change in YoY Net Profit Growth (%) | 0.00% | -133.33% | -100.00% | 120.00% | -120.00% | 212.50% | 687.50% | -833.33% | -16.67% | 83.33% |
BLB Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 10 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 6% |
| 5 Years: | 22% |
| 3 Years: | 15% |
| TTM: | -30% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 18% |
| 5 Years: | -3% |
| 3 Years: | -26% |
| TTM: | -26% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 14% |
| 5 Years: | 21% |
| 3 Years: | -11% |
| 1 Year: | -16% |
| Return on Equity | |
|---|---|
| 10 Years: | 2% |
| 5 Years: | 5% |
| 3 Years: | 5% |
| Last Year: | 4% |
Last Updated: September 5, 2025, 1:05 am
Balance Sheet
Last Updated: June 16, 2025, 12:22 pm
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 |
| Reserves | 108 | 95 | 94 | 91 | 84 | 80 | 72 | 73 | 82 | 88 | 91 | 92 |
| Borrowings | 3 | 7 | 16 | 7 | 13 | 13 | 16 | 2 | 4 | 4 | 0 | 0 |
| Other Liabilities | 1 | 3 | 1 | 1 | 2 | 1 | 10 | 1 | 2 | 0 | 2 | 1 |
| Total Liabilities | 118 | 109 | 116 | 104 | 104 | 99 | 102 | 81 | 94 | 98 | 98 | 98 |
| Fixed Assets | 5 | 4 | 4 | 16 | 19 | 16 | 12 | 11 | 12 | 11 | 4 | 4 |
| CWIP | 6 | 6 | 8 | 6 | 5 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | 26 | 26 | 28 | 21 | 8 | 2 | 1 | 2 | 1 | 0 | 0 | 11 |
| Other Assets | 80 | 72 | 76 | 61 | 72 | 80 | 89 | 68 | 81 | 86 | 94 | 83 |
| Total Assets | 118 | 109 | 116 | 104 | 104 | 99 | 102 | 81 | 94 | 98 | 98 | 98 |
Below is a detailed analysis of the balance sheet data for BLB Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:
- For Equity Capital, as of Mar 2025, the value is 5.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 5.00 Cr..
- For Reserves, as of Mar 2025, the value is 92.00 Cr.. The value appears strong and on an upward trend. It has increased from 91.00 Cr. (Mar 2024) to 92.00 Cr., marking an increase of 1.00 Cr..
- For Borrowings, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
- For Other Liabilities, as of Mar 2025, the value is 1.00 Cr.. The value appears to be improving (decreasing). It has decreased from 2.00 Cr. (Mar 2024) to 1.00 Cr., marking a decrease of 1.00 Cr..
- For Total Liabilities, as of Mar 2025, the value is 98.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 98.00 Cr..
- For Fixed Assets, as of Mar 2025, the value is 4.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 4.00 Cr..
- For CWIP, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
- For Investments, as of Mar 2025, the value is 11.00 Cr.. The value appears strong and on an upward trend. It has increased from 0.00 Cr. (Mar 2024) to 11.00 Cr., marking an increase of 11.00 Cr..
- For Other Assets, as of Mar 2025, the value is 83.00 Cr.. The value appears to be declining and may need further review. It has decreased from 94.00 Cr. (Mar 2024) to 83.00 Cr., marking a decrease of 11.00 Cr..
- For Total Assets, as of Mar 2025, the value is 98.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 98.00 Cr..
Notably, the Reserves (92.00 Cr.) exceed the Borrowings (0.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow - No data available for this post.
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -7.00 | -6.00 | -13.00 | -4.00 | -13.00 | -15.00 | -14.00 | 3.00 | 9.00 | 5.00 | 7.00 | 7.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 25 | 11 | 52 | 27 | 6 | 16 | 0 | 0 | 0 | 0 | 0 | 0 |
| Inventory Days | 16 | 3 | 0 | 16 | 13 | 2 | 8 | 4 | 11 | 34 | 36 | 13 |
| Days Payable | 1 | 2 | 2 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 |
| Cash Conversion Cycle | 40 | 11 | 50 | 43 | 19 | 18 | 7 | 4 | 11 | 34 | 36 | 13 |
| Working Capital Days | 76 | 27 | 89 | 123 | 23 | 61 | 28 | 21 | 42 | 99 | 81 | 43 |
| ROCE % | -3% | 1% | 2% | 2% | 0% | -2% | 3% | 6% | 14% | 9% | 7% | 7% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 18 | Mar 17 | Mar 16 | Mar 15 | Mar 14 |
|---|---|---|---|---|---|
| FaceValue | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Basic EPS (Rs.) | -1.01 | 0.24 | 0.30 | 0.37 | -0.39 |
| Diluted EPS (Rs.) | -1.01 | 0.24 | 0.30 | 0.37 | -0.39 |
| Cash EPS (Rs.) | -0.88 | 0.34 | 0.48 | 0.54 | -0.28 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 16.92 | 17.94 | 19.79 | 19.71 | 21.96 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 16.92 | 17.94 | 19.79 | 19.71 | 21.96 |
| Revenue From Operations / Share (Rs.) | 97.75 | 87.69 | 54.20 | 110.00 | 65.11 |
| PBDIT / Share (Rs.) | 0.01 | 1.55 | 1.39 | 1.15 | 0.08 |
| PBIT / Share (Rs.) | -0.08 | 1.44 | 1.20 | 0.97 | -0.02 |
| PBT / Share (Rs.) | -1.07 | 0.22 | 0.35 | 0.40 | -0.53 |
| Net Profit / Share (Rs.) | -0.98 | 0.23 | 0.29 | 0.36 | -0.39 |
| NP After MI And SOA / Share (Rs.) | -0.98 | 0.23 | 0.29 | 0.36 | -0.39 |
| PBDIT Margin (%) | 0.00 | 1.76 | 2.56 | 1.04 | 0.13 |
| PBIT Margin (%) | -0.08 | 1.64 | 2.21 | 0.88 | -0.03 |
| PBT Margin (%) | -1.09 | 0.26 | 0.65 | 0.36 | -0.81 |
| Net Profit Margin (%) | -1.00 | 0.27 | 0.55 | 0.33 | -0.60 |
| NP After MI And SOA Margin (%) | -1.00 | 0.27 | 0.55 | 0.33 | -0.60 |
| Return on Networth / Equity (%) | -5.81 | 1.33 | 1.51 | 1.87 | -1.78 |
| Return on Capital Employeed (%) | -0.51 | 8.02 | 6.05 | 4.95 | -0.09 |
| Return On Assets (%) | -4.98 | 0.67 | 1.00 | 1.25 | -1.23 |
| Total Debt / Equity (X) | 0.14 | 0.87 | 0.47 | 0.43 | 0.41 |
| Asset Turnover Ratio (%) | 3.56 | 0.88 | 0.42 | 2.14 | 0.85 |
| Current Ratio (X) | 2.98 | 1.40 | 1.68 | 1.67 | 1.68 |
| Quick Ratio (X) | 1.77 | 0.74 | 1.45 | 1.33 | 1.18 |
| Interest Coverage Ratio (X) | 0.01 | 1.28 | 1.51 | 2.01 | 0.16 |
| Interest Coverage Ratio (Post Tax) (X) | 0.00 | 1.20 | 1.25 | 1.64 | 0.22 |
| Enterprise Value (Cr.) | 34.78 | 119.94 | 27.75 | 32.98 | 35.07 |
| EV / Net Operating Revenue (X) | 0.06 | 0.25 | 0.09 | 0.05 | 0.10 |
| EV / EBITDA (X) | 903.43 | 14.67 | 3.78 | 5.41 | 76.95 |
| MarketCap / Net Operating Revenue (X) | 0.05 | 0.08 | 0.05 | 0.03 | 0.04 |
| Price / BV (X) | 0.30 | 0.41 | 0.16 | 0.18 | 0.14 |
| Price / Net Operating Revenue (X) | 0.05 | 0.08 | 0.05 | 0.03 | 0.04 |
| EarningsYield | -0.19 | 0.03 | 0.09 | 0.10 | -0.12 |
After reviewing the key financial ratios for BLB Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 18, the value is 1.00. This value is within the healthy range. There is no change compared to the previous period (Mar 17) which recorded 1.00.
- For Basic EPS (Rs.), as of Mar 18, the value is -1.01. This value is below the healthy minimum of 5. It has decreased from 0.24 (Mar 17) to -1.01, marking a decrease of 1.25.
- For Diluted EPS (Rs.), as of Mar 18, the value is -1.01. This value is below the healthy minimum of 5. It has decreased from 0.24 (Mar 17) to -1.01, marking a decrease of 1.25.
- For Cash EPS (Rs.), as of Mar 18, the value is -0.88. This value is below the healthy minimum of 3. It has decreased from 0.34 (Mar 17) to -0.88, marking a decrease of 1.22.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 18, the value is 16.92. It has decreased from 17.94 (Mar 17) to 16.92, marking a decrease of 1.02.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 18, the value is 16.92. It has decreased from 17.94 (Mar 17) to 16.92, marking a decrease of 1.02.
- For Revenue From Operations / Share (Rs.), as of Mar 18, the value is 97.75. It has increased from 87.69 (Mar 17) to 97.75, marking an increase of 10.06.
- For PBDIT / Share (Rs.), as of Mar 18, the value is 0.01. This value is below the healthy minimum of 2. It has decreased from 1.55 (Mar 17) to 0.01, marking a decrease of 1.54.
- For PBIT / Share (Rs.), as of Mar 18, the value is -0.08. This value is below the healthy minimum of 0. It has decreased from 1.44 (Mar 17) to -0.08, marking a decrease of 1.52.
- For PBT / Share (Rs.), as of Mar 18, the value is -1.07. This value is below the healthy minimum of 0. It has decreased from 0.22 (Mar 17) to -1.07, marking a decrease of 1.29.
- For Net Profit / Share (Rs.), as of Mar 18, the value is -0.98. This value is below the healthy minimum of 2. It has decreased from 0.23 (Mar 17) to -0.98, marking a decrease of 1.21.
- For NP After MI And SOA / Share (Rs.), as of Mar 18, the value is -0.98. This value is below the healthy minimum of 2. It has decreased from 0.23 (Mar 17) to -0.98, marking a decrease of 1.21.
- For PBDIT Margin (%), as of Mar 18, the value is 0.00. This value is below the healthy minimum of 10. It has decreased from 1.76 (Mar 17) to 0.00, marking a decrease of 1.76.
- For PBIT Margin (%), as of Mar 18, the value is -0.08. This value is below the healthy minimum of 10. It has decreased from 1.64 (Mar 17) to -0.08, marking a decrease of 1.72.
- For PBT Margin (%), as of Mar 18, the value is -1.09. This value is below the healthy minimum of 10. It has decreased from 0.26 (Mar 17) to -1.09, marking a decrease of 1.35.
- For Net Profit Margin (%), as of Mar 18, the value is -1.00. This value is below the healthy minimum of 5. It has decreased from 0.27 (Mar 17) to -1.00, marking a decrease of 1.27.
- For NP After MI And SOA Margin (%), as of Mar 18, the value is -1.00. This value is below the healthy minimum of 8. It has decreased from 0.27 (Mar 17) to -1.00, marking a decrease of 1.27.
- For Return on Networth / Equity (%), as of Mar 18, the value is -5.81. This value is below the healthy minimum of 15. It has decreased from 1.33 (Mar 17) to -5.81, marking a decrease of 7.14.
- For Return on Capital Employeed (%), as of Mar 18, the value is -0.51. This value is below the healthy minimum of 10. It has decreased from 8.02 (Mar 17) to -0.51, marking a decrease of 8.53.
- For Return On Assets (%), as of Mar 18, the value is -4.98. This value is below the healthy minimum of 5. It has decreased from 0.67 (Mar 17) to -4.98, marking a decrease of 5.65.
- For Total Debt / Equity (X), as of Mar 18, the value is 0.14. This value is within the healthy range. It has decreased from 0.87 (Mar 17) to 0.14, marking a decrease of 0.73.
- For Asset Turnover Ratio (%), as of Mar 18, the value is 3.56. It has increased from 0.88 (Mar 17) to 3.56, marking an increase of 2.68.
- For Current Ratio (X), as of Mar 18, the value is 2.98. This value is within the healthy range. It has increased from 1.40 (Mar 17) to 2.98, marking an increase of 1.58.
- For Quick Ratio (X), as of Mar 18, the value is 1.77. This value is within the healthy range. It has increased from 0.74 (Mar 17) to 1.77, marking an increase of 1.03.
- For Interest Coverage Ratio (X), as of Mar 18, the value is 0.01. This value is below the healthy minimum of 3. It has decreased from 1.28 (Mar 17) to 0.01, marking a decrease of 1.27.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 18, the value is 0.00. This value is below the healthy minimum of 3. It has decreased from 1.20 (Mar 17) to 0.00, marking a decrease of 1.20.
- For Enterprise Value (Cr.), as of Mar 18, the value is 34.78. It has decreased from 119.94 (Mar 17) to 34.78, marking a decrease of 85.16.
- For EV / Net Operating Revenue (X), as of Mar 18, the value is 0.06. This value is below the healthy minimum of 1. It has decreased from 0.25 (Mar 17) to 0.06, marking a decrease of 0.19.
- For EV / EBITDA (X), as of Mar 18, the value is 903.43. This value exceeds the healthy maximum of 15. It has increased from 14.67 (Mar 17) to 903.43, marking an increase of 888.76.
- For MarketCap / Net Operating Revenue (X), as of Mar 18, the value is 0.05. This value is below the healthy minimum of 1. It has decreased from 0.08 (Mar 17) to 0.05, marking a decrease of 0.03.
- For Price / BV (X), as of Mar 18, the value is 0.30. This value is below the healthy minimum of 1. It has decreased from 0.41 (Mar 17) to 0.30, marking a decrease of 0.11.
- For Price / Net Operating Revenue (X), as of Mar 18, the value is 0.05. This value is below the healthy minimum of 1. It has decreased from 0.08 (Mar 17) to 0.05, marking a decrease of 0.03.
- For EarningsYield, as of Mar 18, the value is -0.19. This value is below the healthy minimum of 5. It has decreased from 0.03 (Mar 17) to -0.19, marking a decrease of 0.22.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in BLB Ltd:
- Net Profit Margin: -1%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: -0.51% (Industry Average ROCE: 21.4%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: -5.81% (Industry Average ROE: 13.12%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 0
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 1.77
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 7.19 (Industry average Stock P/E: 75.86)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.14
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: -1%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Finance & Investments | H.No. 4760-61/23, 3rd Floor, Ansari Road, New Delhi Delhi 110002 | infoblb@blblimited.com http://www.blblimited.com |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Brij Rattan Bagri | Chairman & Managing Director |
| Mr. Anshul Mehra | Executive Director |
| Mrs. Anita Sharma | Independent Director |
| Mr. Gaurav Gupta | Independent Director |
| Mr. Deepak Sethi | Independent Director |
| Mr. Deepak Shrivastava | Independent Director |
FAQ
What is the intrinsic value of BLB Ltd?
BLB Ltd's intrinsic value (as of 08 November 2025) is 5.20 which is 69.41% lower the current market price of 17.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's 90.1 Cr. market cap, FY2025-2026 high/low of 25.0/12.4, reserves of ₹92 Cr, and liabilities of 98 Cr.
What is the Market Cap of BLB Ltd?
The Market Cap of BLB Ltd is 90.1 Cr..
What is the current Stock Price of BLB Ltd as on 08 November 2025?
The current stock price of BLB Ltd as on 08 November 2025 is 17.0.
What is the High / Low of BLB Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of BLB Ltd stocks is 25.0/12.4.
What is the Stock P/E of BLB Ltd?
The Stock P/E of BLB Ltd is 7.19.
What is the Book Value of BLB Ltd?
The Book Value of BLB Ltd is 22.2.
What is the Dividend Yield of BLB Ltd?
The Dividend Yield of BLB Ltd is 0.00 %.
What is the ROCE of BLB Ltd?
The ROCE of BLB Ltd is 6.58 %.
What is the ROE of BLB Ltd?
The ROE of BLB Ltd is 3.99 %.
What is the Face Value of BLB Ltd?
The Face Value of BLB Ltd is 1.00.